Pasithea Therapeutics Corp. (KTTAW) Liabilities from Discontinued Operations (2022 - 2023)
Pasithea Therapeutics' (KTTAW) quarterly Liabilities from Discontinued Operations came in at $299669.0 in Q1 2023, down 6.23% quarter-over-quarter from $319575.0 in Q4 2022.
Analysis
Pasithea Therapeutics Corp. (KTTAW) Liabilities from Discontinued Operations (2022 - 2023) Analysis & Trends
Pasithea Therapeutics has disclosed Liabilities from Discontinued Operations across 2 years of filings, most recently posting $299669.0 for Q1 2023.
- In Q1 2023, Liabilities from Discontinued Operations changed N/A year-over-year to $299669.0; the TTM figure through Mar 2023 stood at $299669.0 (changed N/A YoY), while the FY2022 annual figure was $319575.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations came in at $299669.0 for Q1 2023 at Pasithea Therapeutics, down from $319575.0 in the prior quarter.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of $319575.0 in Q4 2022 to a low of $299669.0 in Q1 2023.
Peer Set